Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...
From erasing your data to setting up Screen Time and Family Sharing, here’s how to turn an old iPhone or iPad into a safe, ...
Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes ...
You don’t need any special hacks – but taking a few simple precautions can save you from pain or an infection.
Zacks Investment Research on MSN
Century Therapeutics (IPSC) upgraded to strong buy: Here's what you should know
Century Therapeutics, Inc. (IPSC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
The storm headed for South Carolina could bring ice and snow to the region, making roads hazardous. But if you have to go out ...
Several campaigning groups will protest at Croke Park on Thursday as Allianz launch their 34th year of sponsorship of the GAA ...
The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...
Neurodegenerative diseases (NDDs) represent a profound challenge to global health, characterized by progressive neuronal dysfunction and loss, leading to ...
The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.
Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results